Skip to main content
Top
Published in: Intensive Care Medicine 5/2010

01-05-2010 | Original

Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia

Authors: Yann-Erick Claessens, Thierry Mathevon, Gérald Kierzek, Sophie Grabar, David Jegou, Eric Batard, Clarisse Loyer, Alain Davido, Pierre Hausfater, Hélène Robert, Leila Lavagna-Perez, Bruno Bernot, Patrick Plaisance, Christophe Leroy, Bertrand Renaud

Published in: Intensive Care Medicine | Issue 5/2010

Login to get access

Abstract

Background

The use at bedside of C-reactive protein (CRP), procalcitonin (PCT) or mid-regional pro-atrial natriuretic peptide (ANP) has been advocated to help management of patients with community-acquired pneumonia (CAP) in emergency medicine.

Objective

To assess the effectiveness of CRP, PCT, and ANP measures in assisting emergency physicians deciding hospital admission for CAP with low risk of complication.

Design

Multicenter, prospective, observational study with blind evaluation.

Setting

Emergency departments of 12 French hospitals.

Patients

Five hundred forty-nine consecutive, immunocompetent adult patients with mild CAP.

Measurements

Centralized and blind measure of baseline CRP, PCT, and ANP; sensitivity, specificity, and positive and negative likelihood ratios for determining hospital admission. Gold standard for admission was defined by experts’ advice combined with admission requirement or death at 28 days. Optimal threshold values were determined by receiver operating characteristic (ROC) curves, and area under curve (AUC) of the three biomarkers was compared.

Results

According to gold standard, 310 (56%) patients required admission and 239 (44%) needed to be discharged. PCT and ANP levels increased with Pneumonia Severity Index risk categories. ANP (AUC 0.76 [95% CI 0.72–0.80]) more accurately predicted admission requirement than did PCT (AUC 0.65 [95% CI 0.61–0.70]) or CRP (AUC 0.59 [95% CI 0.54–0.64]) (both p values <0.01). We determined that 135 pmol/L was a threshold for ANP level to discriminate admission requirement (positive likelihood ratio 7.45 [95% CI 4.22–8.16]).

Conclusions

In a selected population of CAP with low risk of complication, a single ANP measurement was more accurate than CRP and PCT to predict appropriate admission. These results should be confirmed by additional studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chahvakilian P (2001) Quelques données sur les infections bronchopulmonaires. In: Leophonte P, Mouton Y (ed) «Repères sur les infections pulmonaires», 3rd edn, pp 14–24. PIL ed. Feb 2001 Chahvakilian P (2001) Quelques données sur les infections bronchopulmonaires. In: Leophonte P, Mouton Y (ed) «Repères sur les infections pulmonaires», 3rd edn, pp 14–24. PIL ed. Feb 2001
2.
go back to reference Garibaldi RA (1985) Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology, and impact. Am J Med 78:32–37CrossRefPubMed Garibaldi RA (1985) Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology, and impact. Am J Med 78:32–37CrossRefPubMed
3.
go back to reference Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, Angus DC (2003) Pneumonia: still the old man’s friend? Arch Intern Med 163:317–323CrossRefPubMed Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-Zwirble WT, Angus DC (2003) Pneumonia: still the old man’s friend? Arch Intern Med 163:317–323CrossRefPubMed
4.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554CrossRefPubMed Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554CrossRefPubMed
5.
go back to reference Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. Crit Care Med 34:15–21CrossRefPubMed Martin GS, Mannino DM, Moss M (2006) The effect of age on the development and outcome of adult sepsis. Crit Care Med 34:15–21CrossRefPubMed
6.
go back to reference Lave JR, Lin CJ, Fine MJ, Hughes-Cromwick P (1999) The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med 20:189–197CrossRef Lave JR, Lin CJ, Fine MJ, Hughes-Cromwick P (1999) The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med 20:189–197CrossRef
7.
go back to reference Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347–382CrossRefPubMed Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347–382CrossRefPubMed
8.
go back to reference Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL, American Thoracic Society (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL, American Thoracic Society (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed
9.
go back to reference Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C, Infectious Diseases Society of America (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405–1433CrossRefPubMed Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C, Infectious Diseases Society of America (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405–1433CrossRefPubMed
10.
go back to reference Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250CrossRefPubMed Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250CrossRefPubMed
11.
go back to reference Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRefPubMed Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382CrossRefPubMed
12.
go back to reference Fine MJ, Stone RA, Singer DE, Colcy CM, Marrie TJ, Lave JR, Hough LJ, Obrosky S, Schulz R, Ricci EM, Rogers JC, Kapoor WN (1999) Processes and outcomes of care for patients with community-acquired pneumonia. Arch Intern Med 159:970–980CrossRefPubMed Fine MJ, Stone RA, Singer DE, Colcy CM, Marrie TJ, Lave JR, Hough LJ, Obrosky S, Schulz R, Ricci EM, Rogers JC, Kapoor WN (1999) Processes and outcomes of care for patients with community-acquired pneumonia. Arch Intern Med 159:970–980CrossRefPubMed
13.
go back to reference Labarere J, Stone RA, Obrosky DS, Yealy DM, Meehan TP, Fine JM, Graff LG, Fine MJ (2007) Comparision of outcome for low-risk outpatients and inpatients with pneumonia: a propensity-adjusted analysis. Chest 131:480–488CrossRefPubMed Labarere J, Stone RA, Obrosky DS, Yealy DM, Meehan TP, Fine JM, Graff LG, Fine MJ (2007) Comparision of outcome for low-risk outpatients and inpatients with pneumonia: a propensity-adjusted analysis. Chest 131:480–488CrossRefPubMed
14.
go back to reference Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS, Root RK (2003) Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Chest 124:2148–2155CrossRefPubMed Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS, Root RK (2003) Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Chest 124:2148–2155CrossRefPubMed
15.
go back to reference Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 349:1227–1235CrossRefPubMed Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 349:1227–1235CrossRefPubMed
16.
go back to reference Hamm CW, Goldmann BU, Heescen C, Kreymann G, Berger J, Meinertz T (1997) Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337:1648–1653CrossRefPubMed Hamm CW, Goldmann BU, Heescen C, Kreymann G, Berger J, Meinertz T (1997) Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337:1648–1653CrossRefPubMed
17.
go back to reference Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 36:3600–3607 Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 36:3600–3607
18.
go back to reference Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B (2002) Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 34:895–901CrossRefPubMed Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, Riou B (2002) Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 34:895–901CrossRefPubMed
19.
go back to reference Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, Sauca G, Community-Acquired Pneumonia Maresme StudyGroup (2004) Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 125:1335–1342CrossRefPubMed Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, Sauca G, Community-Acquired Pneumonia Maresme StudyGroup (2004) Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 125:1335–1342CrossRefPubMed
20.
go back to reference Smith RP, Lipworth BJ (1995) C-reactive protein in simple community-acquired pneumonia. Chest 107:1028–1031CrossRefPubMed Smith RP, Lipworth BJ (1995) C-reactive protein in simple community-acquired pneumonia. Chest 107:1028–1031CrossRefPubMed
21.
go back to reference Korppi M, Heiskanen-Kosma T, Leinonen M (1997) White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 10:1125–1129CrossRefPubMed Korppi M, Heiskanen-Kosma T, Leinonen M (1997) White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J 10:1125–1129CrossRefPubMed
22.
go back to reference McCarthy PL, Frank AL, Ablow RC, Masters SJ, Dolan TF Jr (1978) Value of the C-reactive protein in the differentiation of bacterial and viral pneumonia. J Paediatr 92:454–456CrossRef McCarthy PL, Frank AL, Ablow RC, Masters SJ, Dolan TF Jr (1978) Value of the C-reactive protein in the differentiation of bacterial and viral pneumonia. J Paediatr 92:454–456CrossRef
23.
go back to reference Ortqvist A, Hedlund J, Wretlind B, Carlstrom A, Kalin M (1995) Diagnostic and prognostic value of IL-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 27:457–462CrossRefPubMed Ortqvist A, Hedlund J, Wretlind B, Carlstrom A, Kalin M (1995) Diagnostic and prognostic value of IL-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 27:457–462CrossRefPubMed
24.
go back to reference Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Muller B (2005) Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37–R45CrossRefPubMed Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Muller B (2005) Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37–R45CrossRefPubMed
25.
go back to reference (2006) [15 consensus conference in infectious disease. Management of community-acquired pneumonia in immunocompetent adults]. Med Mal Infect 36:235–244 (2006) [15 consensus conference in infectious disease. Management of community-acquired pneumonia in immunocompetent adults]. Med Mal Infect 36:235–244
26.
go back to reference Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118:384–392CrossRefPubMed Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118:384–392CrossRefPubMed
27.
28.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
29.
go back to reference Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J (2002) Designing studies to ensure that estimates of test accuracy are transferable. BMJ 324:669–671CrossRefPubMed Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J (2002) Designing studies to ensure that estimates of test accuracy are transferable. BMJ 324:669–671CrossRefPubMed
30.
31.
go back to reference Pewsner D, Battaglia M, Minder C, Marx A, Bucher HC, Egger M (2004) Ruling a diagnosis in or out with “SpPIn” and “SnNOut”: a note of caution. BMJ 329:209–213CrossRefPubMed Pewsner D, Battaglia M, Minder C, Marx A, Bucher HC, Egger M (2004) Ruling a diagnosis in or out with “SpPIn” and “SnNOut”: a note of caution. BMJ 329:209–213CrossRefPubMed
32.
go back to reference Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, The Canadian CAP Working Group (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society; the Canadian Community-Acquired Working group. Clin Infect Dis 31:383–421CrossRefPubMed Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, The Canadian CAP Working Group (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society; the Canadian Community-Acquired Working group. Clin Infect Dis 31:383–421CrossRefPubMed
33.
go back to reference Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS, Root RK (2003) Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Chest 124:2148–2155CrossRefPubMed Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS, Root RK (2003) Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Chest 124:2148–2155CrossRefPubMed
34.
go back to reference Carratala J, Fernandez-Sabe N, Ortega L, Castellsague X, Roson B, Dorca J, Fernandez-Aguera A, Verdaguer R, Martınez J, Manresa F, Gudiol F (2005) Outpatient care compared with hospitalization for community-acquired pneumonia. Ann Intern Med 142:165–172PubMed Carratala J, Fernandez-Sabe N, Ortega L, Castellsague X, Roson B, Dorca J, Fernandez-Aguera A, Verdaguer R, Martınez J, Manresa F, Gudiol F (2005) Outpatient care compared with hospitalization for community-acquired pneumonia. Ann Intern Med 142:165–172PubMed
35.
go back to reference Renaud B, Coma E, Labarere J, Hayon J, Roy PM, Boureaux H, Moritz F, Cibien JF, Guérin T, Carré E, Lafontaine A, Bertrand MP, Santin A, Brun-Buisson C, Fine MJ, Roupie E, Pneumocom Study Investigators (2007) Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter prospective observational controlled cohort study. Clin Infect Dis 44:41–49CrossRefPubMed Renaud B, Coma E, Labarere J, Hayon J, Roy PM, Boureaux H, Moritz F, Cibien JF, Guérin T, Carré E, Lafontaine A, Bertrand MP, Santin A, Brun-Buisson C, Fine MJ, Roupie E, Pneumocom Study Investigators (2007) Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter prospective observational controlled cohort study. Clin Infect Dis 44:41–49CrossRefPubMed
36.
go back to reference Renaud B, Coma E, Hayon J, Gurgui M, Longo C, Blancher M, Jouannic I, Betoulle S, Roupie E, PNEUMOCOM Fine MJ study investigators (2007) Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study. Clin Microbiol Infect 13:923–931CrossRefPubMed Renaud B, Coma E, Hayon J, Gurgui M, Longo C, Blancher M, Jouannic I, Betoulle S, Roupie E, PNEUMOCOM Fine MJ study investigators (2007) Investigation of the ability of the Pneumonia Severity Index to accurately predict clinically relevant outcomes: a European study. Clin Microbiol Infect 13:923–931CrossRefPubMed
37.
go back to reference Masiá M, Gutiérrez F, Shum C, Padilla S, Navarro JC, Flores E, Hernández I (2005) Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest 128:2223–2229CrossRefPubMed Masiá M, Gutiérrez F, Shum C, Padilla S, Navarro JC, Flores E, Hernández I (2005) Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest 128:2223–2229CrossRefPubMed
38.
go back to reference Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M, Riou B (2007) Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 11:R60CrossRefPubMed Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M, Riou B (2007) Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 11:R60CrossRefPubMed
39.
go back to reference Hedlund J, Hansson LO (2000) Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 28:68–73CrossRefPubMed Hedlund J, Hansson LO (2000) Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 28:68–73CrossRefPubMed
40.
go back to reference Polzin A, Pletz M, Erbes R, Raffenberg M, Mauch H, Wagner S, Arndt G, Lode H (2003) Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 21:939–943CrossRefPubMed Polzin A, Pletz M, Erbes R, Raffenberg M, Mauch H, Wagner S, Arndt G, Lode H (2003) Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 21:939–943CrossRefPubMed
41.
go back to reference Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC, for the GenIMS Investigators (2008) Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 52:48–58CrossRefPubMed Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC, for the GenIMS Investigators (2008) Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 52:48–58CrossRefPubMed
42.
go back to reference Boussekey N, Leroy O, Georges H, Devos P, d’Escrivan T, Guery B (2005) Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 33:257–263CrossRefPubMed Boussekey N, Leroy O, Georges H, Devos P, d’Escrivan T, Guery B (2005) Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 33:257–263CrossRefPubMed
43.
go back to reference Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174:84–93CrossRefPubMed Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174:84–93CrossRefPubMed
44.
go back to reference Smith RP, Lipworth BJ (1995) C-reactive protein in simple community-acquired pneumonia. Chest 107:1028–1031CrossRefPubMed Smith RP, Lipworth BJ (1995) C-reactive protein in simple community-acquired pneumonia. Chest 107:1028–1031CrossRefPubMed
45.
go back to reference Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T, CAPNETZ Study Group (2008) Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31:349–355CrossRefPubMed Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T, CAPNETZ Study Group (2008) Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31:349–355CrossRefPubMed
46.
go back to reference Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T, CAPNETZ Study Group (2007) Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 33:2069–2078CrossRefPubMed Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T, CAPNETZ Study Group (2007) Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 33:2069–2078CrossRefPubMed
47.
go back to reference Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F (2007) Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Clin Chem 53:2193–2201CrossRefPubMed Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F (2007) Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Clin Chem 53:2193–2201CrossRefPubMed
48.
go back to reference Prat C, Lacoma A, Dominguez J, Papassotiriou J, Morgenthaler NG, Andreo F, Tudela P, Ruiz-Manzano J, Ausina V (2007) Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia. J Infect 55:400–407CrossRefPubMed Prat C, Lacoma A, Dominguez J, Papassotiriou J, Morgenthaler NG, Andreo F, Tudela P, Ruiz-Manzano J, Ausina V (2007) Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia. J Infect 55:400–407CrossRefPubMed
49.
go back to reference Meleagros L, Gibbs JS, Ghatei MA, Bloom SR (1988) Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. Br Heart J 60:39–44CrossRefPubMed Meleagros L, Gibbs JS, Ghatei MA, Bloom SR (1988) Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. Br Heart J 60:39–44CrossRefPubMed
50.
go back to reference Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663CrossRefPubMed Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663CrossRefPubMed
51.
go back to reference Vila G, Resl M, Stelzeneder D, Struck J, Maier C, Riedl M, Hülsmann M, Pacher R, Luger A, Clodi M (2008) Plasma NT-proBNP increases in response to LPS administration in healthy men. J Appl Physiol 105:1741–1745CrossRefPubMed Vila G, Resl M, Stelzeneder D, Struck J, Maier C, Riedl M, Hülsmann M, Pacher R, Luger A, Clodi M (2008) Plasma NT-proBNP increases in response to LPS administration in healthy men. J Appl Physiol 105:1741–1745CrossRefPubMed
52.
go back to reference Pirracchio R, Deye N, Lukaszewicz AC, Mebazaa A, Cholley B, Matéo J, Mégarbane B, Launay JM, Peynet J, Baud F, Payen D (2008) Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med 36:2542–2546CrossRefPubMed Pirracchio R, Deye N, Lukaszewicz AC, Mebazaa A, Cholley B, Matéo J, Mégarbane B, Launay JM, Peynet J, Baud F, Payen D (2008) Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med 36:2542–2546CrossRefPubMed
53.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, Standards for Reporting of Diagnostic Accuracy (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 138:40–44PubMed Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, Standards for Reporting of Diagnostic Accuracy (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 138:40–44PubMed
Metadata
Title
Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia
Authors
Yann-Erick Claessens
Thierry Mathevon
Gérald Kierzek
Sophie Grabar
David Jegou
Eric Batard
Clarisse Loyer
Alain Davido
Pierre Hausfater
Hélène Robert
Leila Lavagna-Perez
Bruno Bernot
Patrick Plaisance
Christophe Leroy
Bertrand Renaud
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 5/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-010-1818-4

Other articles of this Issue 5/2010

Intensive Care Medicine 5/2010 Go to the issue

Correspondence

Reply to Agrafiotis